Trial site
Umed Clinical Trials Sp. z o.o.
- 15running trials
- 4closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria3 trials
- Asthma2 trials
- Colorectal cancer2 trials
- Type 1 diabetes2 trials
- COPD1 trial
- Crohn's disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Hypertrophic cardiomyopathy1 trial
- IgA nephropathy1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- and 3 more
- Phase
- Phase 311 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Recruiting5 trials
- Completed4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- Kymera Therapeutics Inc.2 trials
- AbbVie1 trial
- Alexion Pharmaceuticals Inc.1 trial
- Argenx1 trial
- and 12 more
Running trials
Not yet recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma2 recruiting
- Chronic spontaneous urticaria2 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Completed
Active, not recruiting
Active, not recruiting
Completed
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026